doi:10.3969/j.issn.1671-2587.2024.03.016

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (3): 394-398.DOI: 10.3969/j.issn.1671-2587.2024.03.016

Previous Articles Next Articles

Received:2024-01-29 Online:2024-06-20 Published:2024-06-24

[1] MONTALVÁ E,RODRÍGUEZ-PERÁLVAREZ M,BLASI A,et al.Consensus statement on hemostatic management,anticoagulation,and antiplatelet therapy in liver transplantation[J].Transplantation,2022,106(6):1123-1131.
[2] ZANETTO A,NORTHUP P,ROBERTS L,et al.Haemostas is in cirrhosis:understanding destabilising factors during acute decompensation[J].J Hepatol,2023,78(5):1037-1047.
[3] 张华鹏,张嘉凯,胡博文.成人肝移植受者围术期凝血功能管理专家共识(2021版)[J].实用器官移植电子杂志,2021,9(2):89-94.
[4] PATRICK N,BETHANY R.Management of coagulation and anticoagulation in liver transplantation candidates[J].Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc,2018,24(8):1119-1132.
[5] TANAKA K A,SHETTAR S,VANDYCK K,et al.Roles of four-factor prothrombin complex concentrate in the management of critical bleeding[J].Transfus Med Rev,2021,35(4):96-103.
[6] REFAAI M A,GOLDSTEIN J N,LEE M L,et al.Increase d risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal[J].Transfusion,2015,55(11):2722-2729.
[7] VAN DIEVOET M A,STEPHENNE X,ROUSSEAUX M,et al.The use of prothrombin complex concentrate in chronic liver disease:a review of the literature[J].Transfus Med,2023,33(3):205-212.
[8] ERDOES G,KOSTER A,ORTMANN E,et al.A Europea n consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients[J].Anaesthesia,2021,76(3):381-392.
[9] HUDA S A,KAHLOWN S,JILANI M H,et al.Managemen t of life-threatening bleeding in patients with mechanical heart valves[J].Cureus,2021,13(6):e15619.
[10] SANER F H,BEZINOVER D.Coagulation management in liver transplantation:a never-ending story[J].Minerva Anestesiol,2018,84(9):1013-1015.
[11] RODGERS G M.Prothrombin complex concentrates in emergency bleeding disorders[J].Am J Hematol,2012,87(9):898-902.
[12] OSTERMANN H,VON HEYMANN C.Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings:efficacy and safety[J].Expert Rev Hematol,2019,12(7):525-540.
[13] DEHNE S,RIEDE C,KLOTZ R,et al.Perioperative prothrombin complex concentrate and fibrinogen administration are associated with thrombotic complications after liver transplant[J].Front Med(Lausanne),2022,9:1043674.
[14] BULUT Y,SAPRU A,ROACH G D.Hemostatic balance in pediatric acute liver failure:epidemiology of bleeding and thrombosis,physiology,and current strategies[J].Front Pediatr,2020,8:618119.
[15] HUANG W T,CANG W C,DERRY K L,et al.Four-factor prothrombin complex concentrate for coagulopathy reversal in patients with liver disease[J].Clin Appl Thromb Hemost,2017,23(8):1028-1035.
[16] TOMIĆ MAHEČIĆ T,BARONICA R,MRZLJAK A,et al.Individualized management of coagulopathy in patients with end-stage liver disease[J].Diagnostics(Basel),2022,12(12):3172.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	Expert consensus drafting group of red blood cell antigen extended matching range. Chinese Expert Consensus on Red Blood Cell Antigen Extended Matching Range [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 289-298.
[2]	MENG Weicheng, CHEN Yaozhen, WANG Yafen, AN Ning, LIU Zhixin, WU Xiaoshuang, WANG Fei, HU Xingbin. The Impact of Reduced Bisphosphoglycerate Mutase（BPGM）Enzyme Activity in Sensitized Red Blood Cells on Oxygen Carrying/Releasing Capacity [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 308-314.
[3]	XIAO Pan, LIU Yulin, XUE Xiaonan, XUE Yingna, LIU Yi, SUN Liping, YU Yang. Proteomic Analysis of Plasma Exosomes from Young Versus Middle-aged People [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 315-325.
[4]	YANG Hao, DONG Shuling, YANG Qiankun, HAN Yue, WANG Shuya, JIN Huifang, ZHENG Lu, TANG Yue. Effect of Double Filtration Plasmapheresis and Plasma Exchange on Blood Type Antibody Removal in ABO-incompatible Kidney Transplantation Recipients: A Single Center Comparative Analysis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 325-331.
[5]	ZHAO Nan, LU Jiangtao, HE Ling, CHEN Xiaoling, ZHANG Wenjie, ZHANG Dafa, TANG Zongsheng. Comprehensive Effect of Autologous Plateletpheresis and Transfusion Technology in Patients with ATAAD [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 332-337.
[6]	CHEN Tingting, HUANG Rong, LING Yu, HU Wenjing. Analysis of Correlation and Influencing Factors between RhD Negative Pregnant Women and the Occurrence of HDFN [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 338-345.
[7]	FAN Chengyan, WEN Yujie, ZHANG Dan, LIAN Xue, LIU Na, SUN Tiecheng, WANG Dongmei, JIA Yanjun, LI Dongmei. Analysis of HLA/HPA Antibody Specificity and Its Impact on Platelet Transfusion Outcomes in Patients with Immune Platelet Transfusion Refractoriness [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 353-358.
[8]	HE Minwei, ZHOU Qianqian, ZHANG Ke, ZHAN Linsheng. Research Advances in Blood Transfusion Medicine in the Year of 2023 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 399-403.
[9]	ZHAO Ziyue, HUANG Weihua, CHA Zhanshan. The Prospect of Combined Application of Platelet-rich Plasma and Mesenchymal Stem Cells in Regenerative Medicine [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(3): 420-426.
[10]	Chinese Blood Transfusion Association Clinical Transfusion Management Committee. Chinese Expert Consensus on Preoperative Advanced Autologous Apheresis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 145-155.
[11]	ZHANG Leiying, YU Yang. Risks of ABO Non-identical Plasma:Cognitive and Clinical Practice [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 164-172.
[12]	LIU Ruining, WANG Deqing. Current Realities and Novel Improvements of Plasma Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 180-186.
[13]	XIE Huihan, SHAO Xiaobao, CHEN Xin, ZHOU Lin, ZHU Peiyuan. Characterization of Salidroside for the Preservation of Apheresis Platelets [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 196-204.
[14]	FAN Rui, FENG Chunyu, WANG Yujing, SHANG Weiwei, TANG Wenfei, MA Haimei, ZHANG Huan. Exploration of Effect on the Quality of Red Blood Cells Suspended during Pressurized Transfusion in Vitro Simulation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 223-229.
[15]	TONG Xinxin, ZHONG Minglu, HUANG huiying, DENG Hui, HUANG Jianyun, WEI Yaming. Transformation of Rh Blood Group in Patients with Blood Diseases Treated with Allogeneic Hematopoietic Stem Cell Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 230-235.